Here, we provide evidence that Rb must normally inThe gene for E2F-1 has been knocked out in mice, teract with E2F to arrest cells in G1. We also show that and the mice develop relatively normally and are fertile it is repression by the Rb-E2F complex, not an Rb-(Field et al., 1996; Yamasaki et al., 1996) . However, they mediated block in transcriptional activation by E2F, that later exhibit testicular atrophy and exocrine gland dysis responsible for this arrest. We show that active represplasia, and they develop a variety of tumors. These resion by Rb-E2F mediates the G1 arrest caused by TGF␤, sults suggest that E2F-1 may be necessary to maintain p16
INK4a
, and contact inhibition. some tissues, but it can also act as a tumor suppressor in several other tissues. However, even though E2F-1 Results is not required for proliferation of most normal cells, tumor cell proliferation is inhibited in E2F-1(Ϫ/Ϫ) mice An E2F Mutant Containing Only the DNA-Binding (Pan et al., 1998; Tsai et al., 1998 Figure 2C ). (C) E2F-DB displaces free E2F and complexes between E2F and Rb family members from E2F sites. Gel retardation assay using extracts from untransfected ( domain (E2F-DB) would displace wild-type E2F and Rb-E2F from the promoter of cell cycle genes. If the transactivation domain of E2F is required for progression of E2F complexes from E2F-binding sites. In fact, it has been demonstrated previously that the E2F-DB will cells from G1 to S phase, then expression of E2F-DB should arrest cells in G1. Alternatively, if the major role block transactivation by wild-type E2F (Fan and Bertino, 1997). We used a mutant form of E2F-1 (amino acids of E2F in the cell cycle is to form an active repressor complex with Rb at the promoter, then displacement of 1-374) containing the DNA-binding domain but lacking the transactivation domain and Rb-binding site to deterwild-type E2F (by E2F-DB) would not block the G1/S transition. In colony formation assays performed with mine the consequence of displacing wild-type E2F and Rb-E2F complexes from promoters.
various Rb(ϩ)/p53(ϩ) cell lines, we did not observe growth suppression when an expression vector for E2F-To demonstrate that E2F-DB indeed blocks E2F function, we cotransfected an expression vector for E2F-DB DB was transfected (results not shown). Western blots of pooled colonies from these assays showed a high along with a reporter containing E2F sites in the context of a minimal promoter. E2F-DB blocked the enhancer level of expression of E2F-DB ( Figure 1B ). When individual clones were examined for expression of the E2F-activity of E2F sites in the minimal promoter setting, even when expression vectors for different E2F family DB, we found levels much greater than that of endogenous E2F-1 ( Figure 1B , Figure 2C , and results not members were cotransfected into Rb(Ϫ) C33A cells or Rb(ϩ) U2OS cells ( Figure 1A and results not shown) , 1996) . Indeed, we found that cells expressing E2F-DB (which lacks the transactivation domain) and there was little evidence of complexes with either free wild-type E2F or with wild-type E2F complexed to were still arrested in G 0 /G1 by serum starvation (Table  1) . In fact the cells consistently arrested more rapidly Rb family proteins ( Figure 1C and results not shown) . These results suggest that in the nucleus (where the and completely than wild-type cells when serum growth factors were deprived. ratio of E2F-DB to E2F sites is even greater than that in INK4a is the Rb pathway. We reasoned that ciation of this complex with the promoter. We transif active repression of cell cycle genes by Rb-E2F is a fected a reporter plasmid containing E2F sites and an primary mechanism through which Rb normally supenhancer (as in Figure 1D ) into U2OS cells. The U2OS presses cell proliferation, then E2F-DB should displace cells are p16
(Ϫ) and contain only hyperphosphorythis repressor complex from promoters of cell cycle lated Rb, so an Rb-E2F complex does not form and E2F genes and overcome the growth suppression by Rb sites do not act as silencers ( Figure 2F) , the endogenous hypobly expressing E2F-DB were treated with TGF␤, and incorporation of BrdU was analyzed as an indication of phosphorylated Rb that accumulates in response to TGF␤ treatment does not appear to arrest cells in G1 DNA synthesis and entry into S phase. As expected, TGF␤ inhibited incorporation of BrdU into wild-type by directly targeting proteins other than E2F. cells; however, it had no effect on BrdU incorporation in the cells stably expressing E2F-DB ( Figure 3A) . Western
TGF␤ Arrests Cells at Two Different Stages in the Cell Cycle blot analysis indicated that E2F-DB blocked the TGF␤-mediated downregulation of cyclin A and cdc2, which
It is thought that CDK4/6 and CDK2 progressively phosphorylate Rb during G1 (Lundberg and Weinberg, 1997). both contain E2F sites in their promoters ( Figure 3B) . Together, the results suggest that preventing interaction CDK4/6 is activated through interaction with D type cyclins initially in G1; then near the end of G1, cyclin E of Rb-E2F with cell cycle genes is sufficient to overcome the G1 block imposed by TGF␤. As with wild-type Mv1Lu is expressed, and it forms an active complex with CDK2. The activity of both CDK4/6 and CDK2 is required for cells, TGF␤ treatment triggered accumulation of hypophosphorylated Rb in cells stably expressing E2F-DB progression of cells from G1 to S phase, and CDK4/6 and CDK2 activity is inhibited in TGF␤-treated cells (Ewen ( Figure 4A (Table 1) . As with wildtype cells, treatment of the E2F-DB-expressing cells with TGF␤ for 24 hr resulted in an initial arrest in G1 (Table 1) . However, when we examined the E2F-DBexpressing cells after incubation with TGF␤ for 48 hr (this 48 hr time point was used for the BrdU studies in Figure 3A above), we found that they were moving from G1 to G2/M, and this exit from G1 continued after 72 hr of treatment with TGF␤. The cells remained arrested in G2/M, which is consistent with the findings that CDK2 activity is required for activation of cdc2 and onset of mitosis in Xenopus (Guadagno and Newport, 1996), and that cyclin E-CDK2 is required for reproduction of centrosomes (Hinchcliffe et al., 1999) . As a control in the above experiments, cells expressing E2F-DB(E132) arrested like wild-type cells when treated with TGF␤ (Table 1) . We conclude that DNA binding of E2F-DB, and therefore the displacement of the Rb-E2F repressor complex from promoters, is required for S phase entry when cells are treated with TGF␤. Furthermore, it is likely that there is enough residual CDK2 activity in the TGF␤-treated cells for assembling origins of replication and al., 1998). Nevertheless, the relative contribution of this repressor activity to cell cycle regulation remained unTherefore, we cultured wild-type Mv1Lu cells and cells expressing E2F-DB at confluence for 3 days. The wildclear. Indeed, it is still thought that transcriptional activation by E2F is essential for progression from G1 to S type cells were plated at higher density and actually reached confluence before the E2F-DB-expressing phase, and that a major function of Rb is to block this transcriptional activation. Moreover, Rb can interact cells. However, while the wild-type cells arrested in response to contact inhibition and maintained a monowith a number of other cellular proteins in addition to E2F, and it is thought that at least some of these other layer on the culture dishes, cells expressing E2F-DB continued to proliferate, causing them to pile on top of interactions must be important for Rb's role in regulating the G1/S transition. Thus, not only is the functional relaeach other (Figures 5A and 5B pressed Rb may function in cell cycle regulation by re-E2F-DB is not able to prevent G1 arrest when Rb is pressing genes with E2F sites. Indeed, we suggest that overexpressed in transfection assays. However, in conoverexpression of Rb leads to short circuiting (binding trast to E2F-DB, coexpression of wild-type E2F-1 did of Rb directly to non-E2F transcription factors that norovercome the G1 arrest resulting from overexpression mally require Rb to first be concentrated at the promoter of Rb (Qin et al., 1995; Sellers et al., 1995) . Why would through interaction with E2F) of a pathway already in E2F-DB overcome G1 arrest by p16 
